Hjem › Plasmacellekræft › New Jersey
Plasmacellekræft kliniske forsøg i New Jersey
4 studier for Plasmacellekræft søger deltagere på steder i New Jersey.
Officiel studietekst (engelsk)
Rutgers University Study of the Genetics of Blood Cancers
- Rutgers University, Piscataway
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 110 · Alle køn · Opdateret 1. okt. 2026 · NCT07714044MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Atlantic Health System Morristown Medical Center, Morristown
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT06152575A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- Hackensack University Medical Center, Hackensack
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT05651932A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
- Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All protocol activities), Montvale
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 26. maj 2026 · NCT07052916Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.